Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by cytochromeon May 09, 2016 3:33pm

110 Views

Post# 24855151

RE:Is It Time to Consider LLLT As a Drug Equivalent?

Dr. Google Bencro,

Yes I've read the editorial. Perhaps you can explain what the biphasic dose response actually is and why too much energy aint a good thing. While you;re at it, how about explaining the importance of treatment time in LLLT? Ooooopps......you probably think the faster the better right??

Bullboard Posts

Three micro-cap value stocks trading at peak pessimism